CIC Edizioni Internazionali. Cardio-metabolic comorbidities in rheumatoid arthritis and SLE. Review. 120 Clinical Dermatology 2013; 1 (2):
|
|
- Alfred David Woods
- 5 years ago
- Views:
Transcription
1 Review Cardio-metabolic comorbidities in rheumatoid arthritis and SLE Andrea Doria Division of Rheumatology University of Padua, Italy Address for correspondence: Division of Rheumatology University of Padua Via Giustiniani, Padua, Italy adoria@unipd.it Summary The progressive improvement of diagnostic and therapeutic alternatives in rheumatic diseases has resulted into reduction in patient mortality and morbidity caused by disease activity. Therefore, new morbidity factors have emerged, i.e. atherosclerosis. It has an early onset and rapid evolution in patients who suffer from a number of rheumatic diseases, including systemic lupus erythematosus, rheumatoid arthritis, sclerodermia, Sjögren syndrome and vasculitis. The immune system and the endothelium are thought to play a crucial role in the atherosclerosis pathogenesis. The immune system is characterized by two different responses to infections: innate and adaptive responses. In the atherosclerotic process, inflammatory cells and molecules are involved which belong to both immune response types. Moreover, the opinion of most authors is that the endothelial damage is to be considered as a predictor for development of the atherosclerotic plaque. In the atherosclerosis pathogenesis, inflammatory and immune aspects play a crucial role. By studying the effect of chemokines, cytokines and autoantibodies, it was possible to better define the role of innate and specific immunity and, in the near future, it will be possible to better define the real biological impact of these mediators in cardiovascular events, setting them as targets for future therapeutic strategies. KEY WORDS: rheumatoid arthritis; systemic lupus erythematosus; atherosclerosis; innate immunity; adaptive immunity. Increased cardio-metabolic complications are usually observed in patients with rheumatoid arthritis and SLE compared to the general population (1). Atherosclerosis is undoubtedly the main cardio-metabolic complication. Historically, atherosclerosis was regarded as a condition characterized by lipid accumulation on vessel walls, resulting into a progressive vessel lumen reduction and the development of a cardiovascular event. Throughout the years, however, evidence has shown that a complex number of immuno-inflammatory processes develop in the vessel wall, which play a crucial role in the initiation and progression of the atherosclerotic process as well as in triggering the atherothrombotic event that in turn causes a cardiovascular event. While it has been established that endothelial dysfunction is the primary cause for the development of atherosclerosis, the mechanisms that originate endothelial dysfunction remain unclear. According to the classical hypothesis of atherosclerosis, traditional risk factors (hypertension, smoking, high cholesterol levels) may induce endothelial dysfunction; however, recent evidence has shown that infections or chronic inflammatory disease may play a role (2). All this factors may contribute to endothelial dysfunction through a common mechanism: immune system activation. Immunity can be distinguished into innate and adaptive, and these two components have different roles and features. It has been demonstrated that the effectors of both immunity components may play a key role in inducing the atherosclerotic process (Figure 1). If we observe the innate component of the immune system, it is clear that pattern recognition receptors, i.e. the receptors that identify common molecular pat- Figure 1 - Key features of innate and acquired immunity in atherogenesis. 120 Clinical Dermatology 2013; 1 (2):
2 Cardio-metabolic comorbidities in rheumatoid arthritis and SLE terns and pathogens, may play a role. These receptors include scavenger receptors, which may engulf modified LDL and turn macrophages into foamy cells. Toll-like receptors are expressed in both macro - phages and endothelial cells that can be activated; activation of endothelial cells may induce adhesion molecules, chemotactic factors and pro-inflammatory cytokines. Nod-like receptors have been recently identified and may be activated by cholesterol crystals, and following inflammasome activation they may determine interleukin 1 production. All these cytokines act within the plaque and play a specific role in the inflammatory process, by amplifying it within the plaque. Pentraxins are a family of proteins that regulate resistance to pathogens. There are two types of pentraxins: C-reactive protein (long pentraxin), and pentraxin 3 (short pentraxin). C-reactive protein activates the complement, may stimulate macrophages to engulf modified LDLs, and may stimulate smooth muscle cells, endothelial cells to produce adhesion molecules, cytokines and chemotactic factors, as well as tissue factor. Therefore, C-reactive protein may play an active role within the plaque, and it has proven to be expressed inside the plaque. C-reactive protein expression within the plaque correlates with its circulating levels. Evidence from several epidemiologic studies has clearly shown that C-reactive protein is an independent predictor for cardiovascular risk in the general population (3). This was confirmed by the Jupiter study (4), published in 2008: the study was conducted in patients without a history a cardiovascular event or ischemic heart disease, had normal cholesterol levels and showed increased C-reactive protein. Patients were randomized to receive rosuvastatin or placebo. Rosuvastatin reduced cardiovascular e - vents by 44%, thus showing that C-reactive protein is a reliable marker for cardiovascular risk. Acquired immunity is also involved in the development of atherosclerotic events: 25% of the cells that infiltrate the atherosclerotic plaque consist of lymphocytes, i.e. the typical cells of adaptive immunity (5). Th1-lymphocytes are known to be pre-atherogenic cells, in particular they seem to be a clonal expansion of CD4+ and CD28- populations. This clonal subpopulation has shown to be expanded in patients with unstable angina. These lymphocytes produce high amounts of interferon-gamma, are self-reactive cells and have a cytotoxic and cytolytic effect on the endothelium. The role of Th17- and Th2-lymphocytes is more controversial. Dendritic cells that penetrate the plaque from the circulation can internalize antigens, for example oxidized LDLs. Then they migrate to lymph nodes, where they present the antigen to naïve CD4-lymphocytes that become effector cells before returning to the circulation. They may re-enter at the plaque level, where they may encounter the autoantigen again, this time presented by the macrophage, by the dendritic cell. This originates a secondary response. B-cells, on the contrary, are not found inside the plaque but outside the vessel wall, where they can originate tertiary structures with a germinal center. This is the place where the auto-antibody response is generated against some autoantigens that are found inside the plaque. Several antigens are present inside the plaque, which may become the target of an antibody response (6). The main antibodies that have shown to be associated with atherosclerosis are those against oxidized LDLs, beta2- glycoprotein 1 and heat shock protein. Several groups have demonstrated that high levels of antioxidized LDL antibodies are associated with ischemic heart disease in humans (7); at the experimental level, it has also been demonstrated that the passive transfer of T cells specific for oxidized LDLs in hypercholesterolemic mice may accelerate the atherosclerotic process (8). Other studies have shown that immunization with oxidized LDLs in animals susceptible to atherosclerosis may cause either a suppression or a worsening of atherogenesis (9), and that infusion with anti-oxidized LDL monoclonal antibodies (in animals susceptible to atherosclerosis) may inhibit oxidized LDL uptake by macrophages (10). Therefore, it is likely that the group of anti-oxidized LDL antibodies include both protective and pathogenetic antibodies. Under normal conditions, anti-oxidized LDL antibodies may help in the removal of oxidized LDLs by macrophages, but in special circumstances e.g. an increased oxidation in smokers there could be a formation of anti-oxidized LDL antibodies directed against different epitopes, and these antibodies may favor oxidized LDL uptake by macrophages, and therefore accelerate atherosclerosis. Protective antibodies might belong to the IgM class, while pathogenetic antibodies to the IgG class (11). The second group of antibodies includes antiphospholipid antibodies, i.e. those associated with arterial or venous thrombosis, both in vivo and in obstetric complications. The main antigen targeted by antiphospholipid antibodies is β2 glycoprotein I, a polypeptide chain consisting of five domains: the fifth domain presents positively charged amino acids and is thought to be responsible for β2 glycoprotein I binding with negatively-charged phospholipid wall. In the majority of cases, anti-β2 glycoprotein I antibodies are directed against the first domain. β2 glycoprotein I not only binds to phospholipids, but also to other negatively-charged molecules, including lipoproteins. β2 glycoprotein I is expressed on endothelial cell membranes and intimal medial borders of human atherosclerotic plaques obtained after carotid endarterectomies. It co-localizes with CD4-positive lymphocytes (12). The role of β2 glycoprotein I in atherosclerosis has been also demonstrated by experiments conducted in animals: immunization of LDL-receptor deficient mice induces anti- β2 antibody production and a worsening of atherosclerosis. If we take lymphocytes from immunized mice and transfer them to mice with a similar genetic background, an acceleration of atherosclerosis will be seen in these mice as well. This will not be seen after lymphocyte depletion. Therefore, β2 gly- Clinical Dermatology 2013; 1 (2):
3 A. Doria coprotein I-specific lymphocyte may increase atherosclerosis and this involves that β2 is a relevant antigen in this process (13). Antiphospholipid antibodies have shown to be associated with several cardiovascular events in humans (14) while the association between antiphospholipid antibodies and subclinical atherosclerosis is more controversial (15). A similar phenomenon is observed with heat shock proteins (HSP 60) that are produced by damaged cells and protect other proteins from denaturation (Figure 2). Heat shock proteins may be produced by endothelial cells in response to stressors (hypertension, smoking, etc.) and represent a target for autoimmunity under certain circumstances. Clinical subclinical and experimental data show that these antibodies are associated with atherosclerosis (16). Results from animal studies are similar to those obtained for β2 glycoprotein I: immunization of LDLreceptor deficient mice with heat shock protein 65 induces antibody production and more atherosclerosis. If we take the antibodies produced by mice or the lymphocytes specific for heat shock proteins and transfer them to animals with a comparable genetic background, these animals will develop more atherosclerosis. Therefore, autoantigens have been identified and isolated within the atherosclerotic plaque, along with Figure 2 - Features of heat shock proteins (HSP 60). autoreactive lymphocytes and antibodies that are found in the circulation but infiltrate the plaque as well. It has been observed that the disease can be induced in experimental animals after immunization with antigens and/or passive transfer of antibodies and lymphocytes (17). This means that atherosclerosis meets five of the criteria used to define autoimmune diseases (Figure 3). Therefore, can we consider atherosclerosis as an autoimmune disease? Perhaps it is, but autoimmunity plays a relevant role in the development of atherosclerosis. As a logical consequence, atherosclerosis appears to be accelerated in autoimmune rheumatic conditions, especially rheumatoid arthritis and SLE (18). The relative risk of cardiovascular events in rheumatoid arthritis is 3.9-fold higher than in the general population, while in SLE the risk is 17-fold higher, and it increases in age groups of young patients: in SLE female patients of the age range an age group that usually is not affected by atherosclerosis the risk of developing a myocardial infarction is 50-fold higher than in the general population (19, 20). Why is atherosclerosis accelerated in autoimmune diseases? Findings from the studies reported in Table 1 show a very high variability of plaque prevalence between studies, ranging from 17 to 40%. Such difference could be explained by the different composition of study populations (mean age, male:female ratio, race, history of cardiovascular events). However, if we observe IMT values, they are quite similar between the studies, ranging from 0.55 mm to 0.71 mm. Since IMT is considered to be normal up to 0.9 mm, the values shown in the Table are all normal, and they are identical regardless of plaque prevalence. In a 2003 study by Roman et al., it was reported that mean IMT was significantly lower in SLE patients compared to healthy subjects (21). In a study published in 2007 (a post mortem study on an appropriate number of patients who died for myocardial infarction, and stratified according to the presence or absence of rheumatoid arthritis), the extent of atherosclerotic plaques was higher in patients who had died for myocardial infarction but without rheumatoid arthritis compared to those who were affected by rheumatoid arthritis. Likewise, the degree of stenosis was higher in patients without rheumatoid arthritis than in the others. Patients with rheumatoid arthritis had more vulnerable plaques (22). Therefore, in patients with rheumatoid arthritis, plaque vulnerability is caused by the inflammation inside the plaque: vulnerability is directly proportional to the degree of inflammation. Therefore, the atherosclerotic plaque hosts several immuno-inflammatory processes that may be very similar to those involved in rheumatoid arthritis. In SLE, in lupus glomerulonephritis, some of the genes that control immuno-inflammatory processes are likely to be the same as those involved in atherosclerosis (23). For these genes, too, there are polymorphisms of both the TNFα gene and of the group of Figure 3 - Diagnostic criteria for autoimmune diseases. 122 Clinical Dermatology 2013; 1 (2):
4 Cardio-metabolic comorbidities in rheumatoid arthritis and SLE Table 1 - Results from the main carotid ultrasound studies in SLE. Carotid ultrasound studies in SLE Manzi Svenungsson Roman Doria Selzer Thompson (1999) (2001) (2003) (2003) (2004) (2008) Patients n Mean age (years) Female % White % 87 NR ~ Previous CVD % Plaque definition >50% than IMT>1 mm >50% than IMT>1.3 mm >50% than >50% than surrounding surrounding surrounding surrounding area area area area Plaque % Mean IMT (mm) 0.71± ± ± ± ± ±0.1 Risk factor evaluation Cross Cross Cross Longitudinal Cross Longitudinal sectional sectional sectional sectional genes involved in interferon signature, i.e. the genetic signature that predisposes and is the first step in the development of autoimmune diseases. Therefore, it is possible that some mediators produced in the synovium or in lupus glomerulonephritis are released into the circulation and induce endothelial dysfunction, regarded as the primum movens, either directly or indirectly through C-reactive protein production. Once the inflammation has developed inside the plaque, this becomes vulnerable and fragile, the fibrous cap breaks down and this leads to the development of the atherothrombotic mechanism and the resulting acute cardiovascular event. However, cardiovascular events especially in thrombophilic patients may also develop as a consequence of thrombus formation on a superficial erosion. It is possible that, in patients with rheumatoid arthritis or SLE, the cardiovascular event develops following rupture of an unstable plaque, but it may also happen that in SLE patients or in those with antiphospholipid antibody syndrome the cardiovascular event is caused by the other mechanism. i.e. thrombus formation on an endothelial erosion. In this respect, it should be noted that endothelial erosions are a frequent occurrence and they are generally repaired by endothelial progenitor cells or by angiogenic myelomonocytic cells. Interestingly, inteferon-alpha the cytokine involved in autoimmune diseases induces apoptosis in myelomonocytic endothelial progenitor cells, and therefore can reduce the repair of endothelial erosions (24). The association between autoimmune inflammatory rheumatic diseases and cardiovascular risk is certainly very strong; we have mainly discussed disease-related factors, namely immuno-inflammatory factors, which are certainly a new field of research; however, we should not neglect traditional risk factors and the pharmacological treatments currently used, that may play a role in the development of atherosclerosis (25). References 1. Symmons DPM, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7, (2011). 2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320: Danesh J, et al. C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease. N Engl J Med 2004;350: Ridker PM, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Eng J Med 2008; 359: Taleb S, et al. Adaptive T cell immune responses and atherogenesis. Cur Opin Pharmacol 2010; 10: Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis Basic mechanisms. Rheum Dis Clin N Am 2005; 31: Fredrikson GN, et al. Identification of immune responses against aldehyde-modified peptide sequences in apob associated with cardiovascular Clinical Dermatology 2013; 1 (2):
5 A. Doria disease. Arterioscl Thromb Vasc Biol 23, 872-8, Zhou X, et al. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Atheroscler Thromb Vasc Biol 26, , Nilsson J, et al. Immunomodulation of atherosclerosis: implications for vaccine development. Atheroscler Tromb Vasc Biol 25, 18-28, Shaw PX, et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 2001 Aug;21(8): Narshi CB, et al. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? Lupus 2011 Jan;20(1): George J, et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999 May 4;99(17): George J, et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation Oct 10;102(15): Kobayashi K, et al. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res 2003 Apr;44(4): Gresele P, et al. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Thromb Res 2009;123(3): SoRelle R. Blood containing high levels of antibodies to heat shock protein 65 (hsp65) were found to be at increased risk of subsequent cardiovascular events. Circulation 2002 Nov 26;106(22). 17. George J, et al. Cellular and humoral immune responses to theat shock proteim both involved in promoting fatty-streak formation in LDL-deficient mice. J Am Coll Cardiol 38: , Shoenfeld Y, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005 Nov 22;112(21): Maradit-Kremers H, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005 Feb;52(2): Fisher LM, et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of firsttime acute myocardial infarction. Am J Cardiol 2004 Jan 15;93(2): Roman MJ, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003 Dec 18; 349(25): Aubry MC, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007 May;34(5): Full LE, et al. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2009, 11: Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121: S21-S Symmons DPM. Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7, (2011). 124 Clinical Dermatology 2013; 1 (2):
THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ
THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ Disclosures: On National Advisory Boards of: (1) Pfizer Pharmaceuticals (2) MSD (3) Roche Pharmaceuticals (4) Abbott International: AfME Rheumatology
More informationThe 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories
The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury
More informationRole of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD
Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal
More informationLupus as a risk factor for cardiovascular disease
Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo
More informationAccelerated Atherosclerosis in Autoimmune Rheumatic Diseases Prof. Andrea Doria
Accelerated Atherosclerosis Andrea Doria Division of Rheumatology University of Padova 1 Endothelial Dysfunction Fatty-Streak Formation Endothelial Leukocyte Endothelial Leukocyte permeability migration
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationAUTOIMMUNITY CLINICAL CORRELATES
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationAUTOIMMUNITY TOLERANCE TO SELF
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationCELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.
!! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)
More informationImmune System AP SBI4UP
Immune System AP SBI4UP TYPES OF IMMUNITY INNATE IMMUNITY ACQUIRED IMMUNITY EXTERNAL DEFENCES INTERNAL DEFENCES HUMORAL RESPONSE Skin Phagocytic Cells CELL- MEDIATED RESPONSE Mucus layer Antimicrobial
More informationBasic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications
12 th Annual Cardiovascular Disease Prevention Symposium February 8, 2013 KEYNOTE ADDRESS Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications Ira Tabas, M.D., Ph.D. Richard J.
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationTracking a Killer Molecule
Tracking a Killer Molecule Mercodia Oxidized LDL ELISA www.mercodia.com Mercodia Oxidized LDL ELISA products Product Catalog No Kit size Oxidized LDL ELISA 10-1143-01 96 wells Oxidized LDL competitive
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationThe Lymphatic System and Body Defenses
PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Lymphatic System and Body Defenses 12PART B Adaptive Defense System: Third Line of Defense Immune
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationInnate immunity. Abul K. Abbas University of California San Francisco. FOCiS
1 Innate immunity Abul K. Abbas University of California San Francisco FOCiS 2 Lecture outline Components of innate immunity Recognition of microbes and dead cells Toll Like Receptors NOD Like Receptors/Inflammasome
More informationThe aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the
The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies
More informationINFLAMMATION &THROMBOSIS INSIGHTS FROM CANTOS TRIAL AHMED NADA, FSCAI ALMOSTAKBAL HOSPITAL, JEDDAH SAUDI ARABIA
INFLAMMATION &THROMBOSIS INSIGHTS FROM CANTOS TRIAL AHMED NADA, FSCAI ALMOSTAKBAL HOSPITAL, JEDDAH SAUDI ARABIA Introduction - Two or three decades ago, many experts predicted that the modification of
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationLow-density lipoprotein as the key factor in atherogenesis too high, too long, or both
Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili
More informationLipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationIS PRE-CLINICAL AUTOIMMUNITY BENIGN?
IS PRE-CLINICAL AUTOIMMUNITY BENIGN? Darcy S. Majka MD, MS Disclosures I have no significant financial or other relationship with the manufacturers of any product or services. Dr. Teodorescu (coauthor)
More informationLIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 : EFFECTS OF LOW DENSITY LIPOPROTEIN APHERESIS
LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 : EFFECTS OF LOW DENSITY LIPOPROTEIN APHERESIS Patrick M. Moriarty, M.D., FACP, Director, Atherosclerosis and LDL-Apheresis Center, University of Kansas Medical
More informationMEDICAL POLICY SUBJECT: INFLAMMATORY MARKERS OF CORONARY ARTERY DISEASE RISK. POLICY NUMBER: CATEGORY: Laboratory Tests
MEDICAL POLICY PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationChapter 35 Active Reading Guide The Immune System
Name: AP Biology Mr. Croft Chapter 35 Active Reading Guide The Immune System Section 1 Phagocytosis plays an important role in the immune systems of both invertebrates and vertebrates. Review the process
More informationDISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none
AUTOIMMUNITY DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias N/A MODULE
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More information1. The scavenger receptor, CD36, functions as a coreceptor for which TLR? a. TLR ½ b. TLR 3 c. TLR 4 d. TLR 2/6
Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS, Andrew H. H. Lichtman, MD, PhD and Shiv Pillai, MBBS, PhD. Chapter 4 (pages 62-74): Innate Immunity
More informationHow the Innate Immune System Profiles Pathogens
How the Innate Immune System Profiles Pathogens Receptors on macrophages, neutrophils, dendritic cells for bacteria and viruses Broad specificity - Two main groups of bacteria: gram positive, gram-negative
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationCottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?
Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,
More informationATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber
ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.
More informationAddressing Vascular Plaque Ruptures
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-vascularplaque-ruptures/3131/
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationCLINICAL OUTCOME Vs SURROGATE MARKER
CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical
More informationInvited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases
Histol Histopathol (2000) 15: 557-571 Histology and Histopathology Cellular and Molecular Biology Invited Review Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular
More informationMAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.
MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationMicrobiology 204: Cellular and Molecular Immunology
Microbiology 204: Cellular and Molecular Immunology Class meets MWF 1:00-2:30PM (*exceptions: no class Fri Sept 23, Fri Oct 14, Nov 11, or Wed Nov 23) Lectures are open to auditors and will be live-streamed
More informationPATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES
PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES Brian R. Holroyd, MD, FACEP, FRCPC Professor and Director, Division of Emergency Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton,
More informationNot only...but also : factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
Rheumatology 2005;44:1492 1502 Advance Access publication 18 October 2005 Review doi:10.1093/rheumatology/kei142 Michael Mason Prize Essay Not only...but also : factors that contribute to accelerated atherosclerosis
More informationDefense mechanism against pathogens
Defense mechanism against pathogens Immune System What is immune system? Cells and organs within an animal s body that contribute to immune defenses against pathogens ( ) Bacteria -Major entry points ;open
More informationKey words: antiphospholipid syndrome, trombosis, pathogenesis
26. XI,. 4/2011,.,..,..,., -..,,. 2GPI. -,.,,., -,, -, -,,,,, IL-1, IL-2, IL-6, IL-8, IL-12, IL-10, TNF, INF-. :,, N. Stoilov, R. Rashkov and R. Stoilov. ANTIPHOSPHOLIPID SYNDROME HISTORICAL DATA, ETI-
More informationA Study of Atherosclerosis in Systemic Vasculitis
Original Article A Study of Atherosclerosis in Systemic Vasculitis Silas Supragya Nelson, Sonjjay Pande, Avadhesh Pratap Singh Kushwah 3 Assistant Professor in the Department of Medicine, NSCB Medical
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationShould we treat everybody over 60 years with a statin? Comprehensive primary prevention in practice
Should we treat everybody over 60 years with a statin? Comprehensive primary prevention in practice Pathogenesis of atherosclerosis A decades-long disease course Inflammation Selectins ICAM IL M-CSF CRP
More informationTolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationImmunology for the Rheumatologist
Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the
More informationThe Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity
The Immune System Biological mechanisms that defend an organism must be 1. triggered by a stimulus upon injury or pathogen attack 2. able to counteract the injury or invasion 3. able to recognise foreign
More informationTolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF
Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells
More informationImmune responses in autoimmune diseases
Immune responses in autoimmune diseases Erika Jensen-Jarolim Dept. of Pathophysiology Medical University Vienna CCHD Lecture January 24, 2007 Primary immune organs: Bone marrow Thymus Secondary: Lymph
More informationMechanisms of Autontibodies
Mechanisms of Autontibodies Production in Rheumatic Diseases Eisa Salehi PhD Tehran University of Medical Sciences Immunology Department Introduction Rheumatic diseases: Cause inflammation, swelling, and
More information1. Overview of Adaptive Immunity
Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive
More informationLupus and the heart. Lupus Foundation of America
Lupus and the heart Lupus Foundation of America Teleconference FEB 2015 Premature Atherosclerotic ti Cardiovascular Disease in Systemic Lupus Erythematosus Joan M. Von Feldt, MD, MSEd Professor of Medicine
More informationComplications of Diabetes mellitus. Dr Bill Young 16 March 2015
Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have
More informationchapter 17: specific/adaptable defenses of the host: the immune response
chapter 17: specific/adaptable defenses of the host: the immune response defense against infection & illness body defenses innate/ non-specific adaptable/ specific epithelium, fever, inflammation, complement,
More informationOverview of the Lymphoid System
Overview of the Lymphoid System The Lymphoid System Protects us against disease Lymphoid system cells respond to Environmental pathogens Toxins Abnormal body cells, such as cancers Overview of the Lymphoid
More informationBerries and Cardiovascular Health
Berries and Cardiovascular Health Britt Burton-Freeman, PhD Institute for Food Safety and Health Illinois Institute of Technology bburton@iit.edu Berry Health Benefits Symposium Westlake Village CA, 2011
More informationAll animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity
1 2 3 4 5 6 7 8 9 The Immune System All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity Figure 43.2 In innate immunity, recognition and
More informationUntil recently, most clinicians and
NEW INSIGHTS INTO THE PATHOLOGY OF CORONARY ARTERY DISEASE * Keith C. Ferdinand, MD, FACC ABSTRACT Atherosclerosis leading to myocardial infarction (MI) is no longer considered a problem of simple mechanical
More informationFluid movement in capillaries. Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system
Capillary exchange Fluid movement in capillaries Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system Lymphatic vessels Lymphatic capillaries permeate
More informationCell-mediated response (what type of cell is activated and what gets destroyed?)
The Immune System Reading Guide (Chapter 43) Name Per 1. The immune response in animals can be divided into innate immunity and adaptive immunity. As an overview, complete this figure indicating the divisions
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationAdaptive immune responses: T cell-mediated immunity
MICR2209 Adaptive immune responses: T cell-mediated immunity Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will discuss the T-cell mediated immune response, how it is activated,
More informationGlossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationThe changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus
184 Journal of Hainan Medical University 2016; 22(16): 184-188 Journal of Hainan Medical University http://www.hnykdxxb.com/ The changes of serum BDNF, blood lipid and PCI in the elderly patients with
More informationHans Strijdom SA Heart Meeting November 2017
Hans Strijdom SA Heart Meeting November 2017 HIV-infection and ART, but not high sensitivity CRP, are associated with markers of vascular function: Results from the Western Cape cohort of the EndoAfrica
More informationMon, Wed, Fri 11:00 AM-12:00 PM. Owen, Judy, Jenni Punt, and Sharon Stranford Kuby-Immunology, 7th. Edition. W.H. Freeman and Co., New York.
Course Title: Course Number: Immunology Biol-341/541 Semester: Fall 2013 Location: HS 268 Time: Instructor: 8:00-9:30 AM Tue/Thur Dr. Colleen M. McDermott Office: Nursing Ed 101 (424-1217) E-mail*: mcdermot@uwosh.edu
More informationKEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers
CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes
More informationVALVULO-METABOLIC RISK IN AORTIC STENOSIS
January 2008 (Vol. 1, Issue 1, pages 21-25) VALVULO-METABOLIC RISK IN AORTIC STENOSIS By Philippe Pibarot, DVM, PhD, FACC, FAHA Groupe de Recherche en Valvulopathies (GRV), Hôpital Laval Research Centre
More informationEffector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells
ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More information11/25/2017. THE IMMUNE SYSTEM Chapter 43 IMMUNITY INNATE IMMUNITY EXAMPLE IN INSECTS BARRIER DEFENSES INNATE IMMUNITY OF VERTEBRATES
THE IMMUNE SYSTEM Chapter 43 IMMUNITY INNATE IMMUNITY EXAMPLE IN INSECTS Exoskeleton made of chitin forms the first barrier to pathogens Digestive system is protected by a chitin-based barrier and lysozyme,
More information2. Innate immunity 2013
1 Innate Immune Responses 3 Innate immunity Abul K. Abbas University of California San Francisco The initial responses to: 1. Microbes: essential early mechanisms to prevent, control, or eliminate infection;
More informationPathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD
Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from
More informationATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.
ATHEROSCLEROSIS Atherosclerosis Atherosclerosis is a disease process affecting the intima of the aorta and large and medium arteries, taking the form of focal thickening or plaques of fibrous tissue and
More informationAdaptive Immunity: Specific Defenses of the Host
17 Adaptive Immunity: Specific Defenses of the Host SLOs Differentiate between innate and adaptive immunity, and humoral and cellular immunity. Define antigen, epitope, and hapten. Explain the function
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationFor unclear reasons, only about 40% of patients with calcific aortic stenosis also have coronary
Αθηροσκλήρωση και ασβεστοποιός στένωση της αορτικής βαλβίδας. Οµοιότητες και διαφορές Ν. Μεζίλης Κλινική «Άγιος Λουκάς» Ασβεστοποιός στένωση της αορτικής βαλβίδας: Μία ακόµα µορφή αθηρωµάτωσης; Some observations
More informationIntroduction to Immunopathology
MICR2209 Introduction to Immunopathology Dr Allison Imrie 1 Allergy and Hypersensitivity Adaptive immune responses can sometimes be elicited by antigens not associated with infectious agents, and this
More informationThe Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep
The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep invaders out of the body (pp. 772 773; Fig. 21.1; Table
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationPathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More informationVulnerable Plaque. Atherothrombosis
Vulnerable Plaque Nuove acquisizioni sull'aterosclerosi: placca vulnerabile Marina Camera Dip. Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano & Laboratorio di Biologia Cellulare
More informationTCR, MHC and coreceptors
Cooperation In Immune Responses Antigen processing how peptides get into MHC Antigen processing involves the intracellular proteolytic generation of MHC binding proteins Protein antigens may be processed
More informationNOTES: CH 43, part 2 Immunity; Immune Disruptions ( )
NOTES: CH 43, part 2 Immunity; Immune Disruptions (43.3-43.4) Activated B & T Lymphocytes produce: CELL-MEDIATED IMMUNE RESPONSE: involves specialized T cells destroying infected host cells HUMORAL IMMUNE
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationInflammation, rheumatoid arthritis and cardiovascular disease
Inflammation, rheumatoid arthritis and cardiovascular disease Yvette Meißner, Pharmacoepidemiology, German Rheumatism Research Centre www. chronische-entzuendung.org Outline I. Cardiovascular disease II.
More informationAssessment for Early Cardiovascular Risk in Pediatric Rheumatic Disease
Assessment for Early Cardiovascular Risk in Pediatric Rheumatic Disease by Pascal Norman Tyrrell A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute
More informationIschemic heart disease is the leading cause of
The impact of C-Reactive Protein: A Look at the Most Recent Studies and Trials By Davinder S. Jassal, MD, FRCPC; and Blair O Neill, MD, FRCPC, FACC Ischemic heart disease is the world s leading killer,
More informationDeterminants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco
Determinants of Immunogenicity and Tolerance Abul K. Abbas, MD Department of Pathology University of California San Francisco EIP Symposium Feb 2016 Why do some people respond to therapeutic proteins?
More informationPathogenesis of atherosclerosis in rheumatoid arthritis
Pathogenesis of atherosclerosis in rheumatoid arthritis JR Pambudi 1, H Isbagio 1 1 Division of Rheumatology, Department of Internal Medicine, University of Indonesia School of Medicine/ Cipto Mangunkusumo
More informationLU:research Institutional Repository of Lund University
LU:research Institutional Repository of Lund University This is an author produced version of a paper published in Atherosclerosis. This paper has been peer-reviewed but does not include the final publisher
More informationThe JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009
The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain
More information